title: Platelet-active drugs : the relationships among dose, effectiveness, and side effects.
authors.affiliation: Department of Medicine and Aging, Università degli Studi G D'Annunzio, Chieti, Italy. Cpatrono@unich.it
authors.forename: C
authors.initials: C
authors.lastname: Patrono
authors.forename: B
authors.initials: B
authors.lastname: Coller
authors.forename: J E
authors.initials: JE
authors.lastname: Dalen
authors.forename: G A
authors.initials: GA
authors.lastname: FitzGerald
authors.forename: V
authors.initials: V
authors.lastname: Fuster
authors.forename: M
authors.initials: M
authors.lastname: Gent
authors.forename: J
authors.initials: J
authors.lastname: Hirsh
authors.forename: G
authors.initials: G
authors.lastname: Roth
mesh_terms: D001241:Aspirin / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D005260:Female; D005343:Fibrinolytic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D011225:Pre-Eclampsia / Q000517:prevention & control; D011247:Pregnancy; D013927:Thrombosis / Q000517:prevention & control*
chemical_list: D016861:Cyclooxygenase Inhibitors; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D004176:Dipyridamole; D001241:Aspirin